SCHEMBL11903464

SCHEMBL11903464

Fc1ccc(-c2nc3cc(OC(F)(F)F)ccc3[nH]2)cc1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 4/20 0.60
KDM4E B2RXH2 2/20 0.54
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
CHEK2 O96017 4/20 0.48
CBFB Q13951 2/20 0.48
RUNX1 Q01196 1/20 0.47
ALDH1A1 P00352 2/20 0.47
PKM P14618 2/20 0.47
GUSB P08236 1/20 0.45
NR4A2 P43354 1/20 0.45
BACE1 P56817 1/20 0.45
DHODH Q02127 1/20 0.44
TRPA1 O75762 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11903468 0.89 TRPV1 (0.74) TRPV1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL11903494 0.88 TRPV1 (0.62) TRPV1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL11903440 0.88 TRPV1 (0.58) TRPV1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL11903647 0.88 TRPV1 (0.62) TRPV1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL11903477 0.87 TRPV1 (0.57) TRPV1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL11903467 0.86 TRPV1 (0.57) TRPV1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL11903515 0.84 TRPV1 (0.58) TRPV1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL13305849 0.84 TRPV1 (0.55) TRPV1CHEK2CBFBRUNX1
SCHEMBL11903531 0.84 TRPV1 (0.58) TRPV1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL1664917 0.83 CHEK2 (0.56) TRPV1KDM4ECHEK2RUNX1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8293780-B1 Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making U.S. DEPARTMENT OF ENERGY (US) 2012-10-23 US disclosed
US-8242284-B1 Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 2012-08-14 US disclosed